KA
IBB icon

Kovack Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Kovack Advisors’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-6
Closed -$6K – 451
2018
Q3 		$6K Buy
+6
New +$707 ﹤0.01% 437

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Kovack Advisors's IBB Position: Q2 2026 in Review

Kovack Advisors reduced its iShares Biotechnology ETF (IBB) stake by 12% in Q2 2026, selling an estimated $59K and leaving 2,551 shares worth $485K. The position accounts for 0.02% of the portfolio, ranked #635.

Kovack Advisors first reported a position in IBB in Q1 2015 and has held it in 45 quarters since. The position peaked at $825K in Q4 2017. 956 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Kovack Advisors held 2,551 shares of iShares Biotechnology ETF worth $485K as of Q2 2026.
  • Kovack Advisors sold 343 iShares Biotechnology ETF shares in Q2 2026, an estimated $59K.
  • iShares Biotechnology ETF made up 0.02% of Kovack Advisors's portfolio in Q2 2026, its #635 holding.
  • Kovack Advisors first reported a position in iShares Biotechnology ETF in Q1 2015 and has held it in 45 quarters since.
  • Kovack Advisors's iShares Biotechnology ETF position peaked at $825K in Q4 2017.
  • 956 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Kovack Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.